AstraZeneca, in collaboration with HUTCHMED, has submitted a New Drug Application to the US FDA for ORPATHYS® (savolitinib) ...

A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with ...

There are around 125,000 lung cancer deaths in the U.S. every year and around 32,800 lung cancer deaths in the U.K. annually.

TAHLEQUAH, Okla. The American Lung Association’s statistics on lung cancer in Oklahoma reveals those surviving the disease ...

Pre-screening is now underway to enroll the single patient in Cohort 2, who is expected to receive RC220 at 100 mg/m 2 with ...

Fortunately, most lung nodules are harmless. Around 95% of lung nodules tend to be benign (non-cancerous), and are instead ...

AMAZE-lung shows promising activity with amivantamab, lazertinib and bevacizumab after third-generation EGFR TKI resistance ...

A new study shows that a simple index combining hemoglobin and the albumin-to-alkaline phosphatase ratio can predict survival ...

Long-term exposure to cigarette smoke reshapes distinct populations of lung stem cells, and the reshaped cell state deciding ...

Healthline Editor-in-Chief Robin Hough talks with Gini Harrison, a psychologist and his friend of nearly 30 years, who never ...

Theodore Wagener, PhD, discusses an Ohio State feasibility study testing psilocybin-assisted therapy for depression in patients with non–small cell lung cancer. Theodore Wagener, PhD, founding ...

The Lung Cancer Canada Breathe Forward Award is a new $200,000 national innovation challenge supporting practical and ...